Showing 2642 results
- Media Release /Novartis secured 79.6 percent acceptance by MorphoSys shareholders during the initial acceptance period, reaching the minimum 65% acceptance thresholdSettlement of the shares tendered during the…
- Media Release /Primary results of the Scemblix® ASC4FIRST pivotal Phase III study in first-line Ph+ CML-CP supporting third US FDA Breakthrough Therapy designation, to be detailed in the ASCO Press Program and the…
- Media Release /Transaction reinforces company’s strategic focus on developing next-generation treatment options for patients living with cancerMariana Oncology is a preclinical-stage biotechnology company focused…
- Media Release /There is currently no evidence-based treatment for the smallest babies with malaria The CALINA study tested a new ratio and dose of Coartem® (artemether- lumefantrine) to account for metabolic…
- Clinical Trials /
- Clinical Trials /
- Clinical Trials /
- Clinical Trials /
- Clinical Trials /
- Clinical Trials /
Pagination
- ‹ Previous page
- 1
- …
- 244
- 245
- 246
- 247
- 248
- 249
- 250
- …
- 265
- › Next page